Clinical and Molecular Methods in Drug Development: Neoadjuvant Systemic Therapy in Breast Cancer as a Model.

about

Clinical and Molecular Methods in Drug Development: Neoadjuvant Systemic Therapy in Breast Cancer as a Model.

Item

http://www.wikidata.org/entity/Q52984715

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Clinical and Molecular Methods ...... y in Breast Cancer as a Model.

@en

Clinical and Molecular Methods ...... y in Breast Cancer as a Model.

@nl

type

Item

label

Clinical and Molecular Methods ...... y in Breast Cancer as a Model.

@en

Clinical and Molecular Methods ...... y in Breast Cancer as a Model.

@nl

prefLabel

Clinical and Molecular Methods ...... y in Breast Cancer as a Model.

@en

Clinical and Molecular Methods ...... y in Breast Cancer as a Model.

@nl

P1476

Clinical and Molecular Methods ...... y in Breast Cancer as a Model.

@en

P2093

Sofia Braga

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Neoadjuvant therapy as a platform for drug development and approval in breast cancer

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Cancer statistics, 2013

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction

Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer.

Pre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic review.

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients.

P304

251-280

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-1-4939-3347-1_15

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1395

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26910079

http://www.w3.org/2001/XMLSchema#string